{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:12:22Z","timestamp":1793344342203,"version":"4.5.0"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-025-00748-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:44:50Z","timestamp":1751355890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3924-5270","authenticated-orcid":false,"given":"Emmanuel","family":"Amabebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Tatiparthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth K.","family":"Kammala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren S.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"748_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2147\/IJWH.S383333","volume":"15","author":"CA Muzny","year":"2023","unstructured":"Muzny, C. A. & Sobel, J. D. Understanding and preventing recurring bacterial vaginosis: important considerations for clinicians. Int. J. Women\u2019s. Health 15, 1317\u20131325 (2023).","journal-title":"Int. J. Women\u2019s. Health"},{"key":"748_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S. & Barnabas, R. V. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex. Transm. Dis. 46, 304\u2013311 (2019).","journal-title":"Sex. Transm. Dis."},{"key":"748_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","volume":"34","author":"EH Koumans","year":"2007","unstructured":"Koumans, E. H. et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis. 34, 864\u2013869 (2007).","journal-title":"Sex. Transm. Dis."},{"key":"748_CR4","doi-asserted-by":"publisher","unstructured":"Amabebe, E. & Anumba, D. O. C. The vaginal microenvironment: the physiologic role of lactobacilli. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2018.00181 (2018).","DOI":"10.3389\/fmed.2018.00181"},{"key":"748_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00284-022-02771-2","volume":"79","author":"E Amabebe","year":"2022","unstructured":"Amabebe, E. & Anumba, D. O. C. Mechanistic insights into immune suppression and evasion in bacterial vaginosis. Curr. Microbiol. 79, 84 (2022).","journal-title":"Curr. Microbiol."},{"key":"748_CR6","doi-asserted-by":"publisher","first-page":"225 e221","DOI":"10.1016\/j.ajog.2021.09.018","volume":"226","author":"AT Gustin","year":"2022","unstructured":"Gustin, A. T. et al. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis. Am. J. Obstet. Gynecol. 226, 225 e221\u2013225.e215 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR7","doi-asserted-by":"publisher","first-page":"e248661","DOI":"10.1001\/jamanetworkopen.2024.8661","volume":"7","author":"G Raba","year":"2024","unstructured":"Raba, G. et al. Efficacy of dequalinium chloride vs metronidazole for the treatment of bacterial vaginosis: a randomized clinical trial. JAMA Netw. Open 7, e248661 (2024).","journal-title":"JAMA Netw. Open"},{"key":"748_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/aid.2018.0304","volume":"35","author":"LR McKinnon","year":"2019","unstructured":"McKinnon, L. R. et al. The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res. Hum. Retroviruses 35, 219\u2013228 (2019).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"748_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/aji.70003","volume":"92","author":"MM Jordan","year":"2024","unstructured":"Jordan, M. M., Amabebe, E., Khanipov, K. & Taylor, B. D. Scoping review of microbiota dysbiosis and risk of preeclampsia. Am. J. Reprod. Immunol. 92, e70003 (2024).","journal-title":"Am. J. Reprod. Immunol."},{"key":"748_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.AOG.0000247627.84791.91","volume":"109","author":"JE Allsworth","year":"2007","unstructured":"Allsworth, J. E. & Peipert, J. F. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet. Gynecol. 109, 114\u2013120 (2007).","journal-title":"Obstet. Gynecol."},{"key":"748_CR11","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108, 4680\u20134687 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"748_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00816-24","volume":"62","author":"JR Schwebke","year":"2024","unstructured":"Schwebke, J. R., Nyirjesy, P., Dsouza, M. & Getman, D. Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing. J. Clin. Microbiol. 62, e0081624 (2024).","journal-title":"J. Clin. Microbiol."},{"key":"748_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon, C., Colebunders, R. & Crucitti, T. The global epidemiology of bacterial vaginosis: a systematic review. Am. J. Obstet. Gynecol. 209, 505\u2013523 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12905-023-02236-z","volume":"23","author":"K Chow","year":"2023","unstructured":"Chow, K. et al. Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments. BMC Womens Health 23, 112 (2023).","journal-title":"BMC Womens Health"},{"key":"748_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/10600280231190701","volume":"58","author":"E Watkins","year":"2024","unstructured":"Watkins, E. et al. Bacterial vaginosis treatment patterns, associated complications, and health care economic burden of women with medicaid coverage in the United States. Ann. Pharmacother. 58, 480\u2013493 (2024).","journal-title":"Ann. Pharmacother."},{"key":"748_CR16","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0079","volume":"13","author":"E Watkins","year":"2024","unstructured":"Watkins, E. et al. Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA. J. Comp. Eff. Res 13, e230079 (2024).","journal-title":"J. Comp. Eff. Res"},{"key":"748_CR17","doi-asserted-by":"publisher","first-page":"e74378","DOI":"10.1371\/journal.pone.0074378","volume":"8","author":"JE Bilardi","year":"2013","unstructured":"Bilardi, J. E. et al. The burden of bacterial vaginosis: women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS ONE8, e74378 (2013).","journal-title":"PLoS ONE"},{"key":"748_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jiw121","volume":"214","author":"CA Muzny","year":"2016","unstructured":"Muzny, C. A. & Schwebke, J. R. Pathogenesis of bacterial vaginosis: discussion of current hypotheses. J. Infect. Dis. 214, S1\u2013S5 (2016).","journal-title":"J. Infect. Dis."},{"key":"748_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00253-017-8659-9","volume":"102","author":"G Reid","year":"2018","unstructured":"Reid, G. Is bacterial vaginosis a disease?. Appl. Microbiol. Biotechnol. 102, 553\u2013558 (2018).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"748_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00837-22","volume":"61","author":"CA Muzny","year":"2023","unstructured":"Muzny, C. A. et al. State of the art for diagnosis of bacterial vaginosis. J. Clin. Microbiol. 61, e0083722 (2023).","journal-title":"J. Clin. Microbiol."},{"key":"748_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent, R. P., Krohn, M. A. & Hillier, S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29, 297\u2013301 (1991).","journal-title":"J. Clin. Microbiol."},{"key":"748_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel, R. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14\u201322 (1983).","journal-title":"Am. J. Med."},{"key":"748_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.631972","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen, X., Lu, Y., Chen, T. & Li, R. The female vaginal microbiome in health and bacterial vaginosis. Front. Cell Infect. Microbiol. 11, 631972 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR24","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1093\/cid\/ciac021","volume":"74","author":"CA Muzny","year":"2022","unstructured":"Muzny, C. A. et al. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin. Infect. Dis. 74, S144\u2013S151 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"748_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/QCO.0000000000000620","volume":"33","author":"CA Muzny","year":"2020","unstructured":"Muzny, C. A., Laniewski, P., Schwebke, J. R. & Herbst-Kralovetz, M. M. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr. Opin. Infect. Dis. 33, 59\u201365 (2020).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"748_CR26","doi-asserted-by":"publisher","unstructured":"Muzny, C. A. & Schwebke, J. R. Asymptomatic bacterial vaginosis: to treat or not to treat? Curr. Infect. Dis. Rep. https:\/\/doi.org\/10.1007\/s11908-020-00740-z (2020).","DOI":"10.1007\/s11908-020-00740-z"},{"key":"748_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/OLQ.0000000000001178","volume":"47","author":"CA Muzny","year":"2020","unstructured":"Muzny, C. A. & Kardas, P. A narrative review of current challenges in the diagnosis and management of bacterial vaginosis. Sex. Transm. Dis. 47, 441\u2013446 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"748_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski, K. A. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm. Rep. 70, 1\u2013187 (2021).","journal-title":"MMWR Recomm. Rep."},{"key":"748_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/ppe.12947","volume":"37","author":"MA Klebanoff","year":"2023","unstructured":"Klebanoff, M. A. et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: systematic review and individual participant data meta-analysis. Paediatr. Perinat. Epidemiol. 37, 239\u2013251 (2023).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"748_CR30","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2214-109X(18)30543-6","volume":"7","author":"EM McClure","year":"2019","unstructured":"McClure, E. M. & Goldenberg, R. L. Use of antibiotics to reduce preterm birth. Lancet Glob. Health 7, e18\u2013e19 (2019).","journal-title":"Lancet Glob. Health"},{"key":"748_CR31","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/S0140-6736(18)31617-9","volume":"392","author":"D Subtil","year":"2018","unstructured":"Subtil, D. et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 392, 2171\u20132179 (2018).","journal-title":"Lancet"},{"key":"748_CR32","first-page":"231","volume":"92","author":"HJ Odendaal","year":"2002","unstructured":"Odendaal, H. J., Popov, I., Schoeman, J., Smith, M. & Grove, D. Preterm labour\u2013is bacterial vaginosis involved?. S. Afr. Med. J. 92, 231\u2013234 (2002).","journal-title":"S. Afr. Med. J."},{"key":"748_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJM200002243420802","volume":"342","author":"JC Carey","year":"2000","unstructured":"Carey, J. C. et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N. Engl. J. Med. 342, 534\u2013540 (2000).","journal-title":"N. Engl. J. Med."},{"key":"748_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1471-0528.1999.tb08363.x","volume":"106","author":"GM Vermeulen","year":"1999","unstructured":"Vermeulen, G. M. & Bruinse, H. W. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br. J. Obstet. Gynaecol. 106, 652\u2013657 (1999).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"748_CR35","doi-asserted-by":"publisher","unstructured":"Lamont, R. F. Advances in the prevention of infection-related preterm birth. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2015.00566 (2015).","DOI":"10.3389\/fimmu.2015.00566"},{"key":"748_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajog.2019.05.020","volume":"221","author":"MG Gravett","year":"2019","unstructured":"Gravett, M. G. Successful treatment of intraamniotic infection\/inflammation: a paradigm shift. Am. J. Obstet. Gynecol. 221, 83\u201385 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR37","doi-asserted-by":"publisher","first-page":"S759","DOI":"10.1093\/cid\/civ771","volume":"61","author":"KA Workowski","year":"2015","unstructured":"Workowski, K. A. Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin. Infect. Dis. 61, S759\u2013S762 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"748_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski, K. A., Bolan, G. A. & Centers for Disease, C. & Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm. Rep. 64, 1\u2013137 (2015).","journal-title":"MMWR Recomm. Rep."},{"key":"748_CR39","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0956462418785451","volume":"29","author":"J Sherrard","year":"2018","unstructured":"Sherrard, J., Wilson, J., Donders, G., Mendling, W. & Jensen, J. S. 2018 European (IUSTI\/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J. STD AIDS 29, 1258\u20131272 (2018).","journal-title":"Int J. STD AIDS"},{"key":"748_CR40","doi-asserted-by":"publisher","first-page":"157 e151","DOI":"10.1016\/j.ajog.2019.08.008","volume":"222","author":"MC Verwijs","year":"2020","unstructured":"Verwijs, M. C., Agaba, S. K., Darby, A. C. & van de Wijgert, J. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am. J. Obstet. Gynecol. 222, 157 e151\u2013157.e113 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/ZZKH4176","volume":"26","author":"L Armstrong-Buisseret","year":"2022","unstructured":"Armstrong-Buisseret, L. et al. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT. Health Technol. Assess. 26, 1\u2013170 (2022).","journal-title":"Health Technol. Assess."},{"key":"748_CR42","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/AOG.0000000000004805","volume":"139","author":"C Mauck","year":"2022","unstructured":"Mauck, C. et al. Single-dose, bioadhesive clindamycin 2% gel for bacterial vaginosis: a randomized controlled trial. Obstet. Gynecol. 139, 1092\u20131102 (2022).","journal-title":"Obstet. Gynecol."},{"key":"748_CR43","doi-asserted-by":"publisher","unstructured":"Oduyebo, O. O., Anorlu, R. I. & Ogunsola, F. T. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst. Rev. 3, CD006055. https:\/\/doi.org\/10.1002\/14651858.CD006055.pub2 (2009).","DOI":"10.1002\/14651858.CD006055.pub2"},{"key":"748_CR44","doi-asserted-by":"publisher","first-page":"e34540","DOI":"10.1371\/journal.pone.0034540","volume":"7","author":"CS Bradshaw","year":"2012","unstructured":"Bradshaw, C. S. et al. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS ONE7, e34540 (2012).","journal-title":"PLoS ONE"},{"key":"748_CR45","doi-asserted-by":"publisher","first-page":"211 e211","DOI":"10.1016\/j.ajog.2010.10.898","volume":"204","author":"JR Schwebke","year":"2011","unstructured":"Schwebke, J. R. & Desmond, R. A. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am. J. Obstet. Gynecol. 204, 211 e211\u2013211.e216 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR46","doi-asserted-by":"publisher","unstructured":"Muzny, C. A. & Sobel, J. D. The role of antimicrobial resistance in refractory and recurrent bacterial vaginosis and current recommendations for treatment. Antibiotics https:\/\/doi.org\/10.3390\/antibiotics11040500 (2022).","DOI":"10.3390\/antibiotics11040500"},{"key":"748_CR47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/cid\/civ353","volume":"61","author":"CA Muzny","year":"2015","unstructured":"Muzny, C. A. & Schwebke, J. R. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin. Infect. Dis. 61, 601\u2013606 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"748_CR48","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ajog.2005.11.041","volume":"194","author":"JD Sobel","year":"2006","unstructured":"Sobel, J. D. et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am. J. Obstet. Gynecol. 194, 1283\u20131289 (2006).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","volume":"106","author":"A Swidsinski","year":"2005","unstructured":"Swidsinski, A. et al. Adherent biofilms in bacterial vaginosis. Obstet. Gynecol. 106, 1013\u20131023 (2005).","journal-title":"Obstet. Gynecol."},{"key":"748_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/QCO.0b013e32835c20cd","volume":"26","author":"H Verstraelen","year":"2013","unstructured":"Verstraelen, H. & Swidsinski, A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr. Opin. Infect. Dis. 26, 86\u201389 (2013).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"748_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/QCO.0000000000000516","volume":"32","author":"H Verstraelen","year":"2019","unstructured":"Verstraelen, H. & Swidsinski, A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment: 2018 update. Curr. Opin. Infect. Dis. 32, 38\u201342 (2019).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"748_CR52","first-page":"567","volume":"29","author":"A Swidsinski","year":"2014","unstructured":"Swidsinski, A. et al. Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). Histol. Histopathol. 29, 567\u2013587 (2014).","journal-title":"Histol. Histopathol."},{"key":"748_CR53","doi-asserted-by":"publisher","first-page":"97.e91","DOI":"10.1016\/j.ajog.2007.06.039","volume":"198","author":"A Swidsinski","year":"2008","unstructured":"Swidsinski, A. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am. J. Obstet. Gynecol. 198, 97.e91\u201397.e96 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1100029","volume":"5","author":"C Abbe","year":"2023","unstructured":"Abbe, C. & Mitchell, C. M. Bacterial vaginosis: a review of approaches to treatment and prevention. Front Reprod. Health 5, 1100029 (2023).","journal-title":"Front Reprod. Health"},{"key":"748_CR55","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/cis1030","volume":"56","author":"CS Bradshaw","year":"2013","unstructured":"Bradshaw, C. S. et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin. Infect. Dis. 56, 777\u2013786 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"748_CR56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa2405404","volume":"392","author":"LA Vodstrcil","year":"2025","unstructured":"Vodstrcil, L. A. et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N. Engl. J. Med. 392, 947\u2013957 (2025).","journal-title":"N. Engl. J. Med."},{"key":"748_CR57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","volume":"47","author":"MAB Petrina","year":"2017","unstructured":"Petrina, M. A. B., Cosentino, L. A., Rabe, L. K. & Hillier, S. L. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe 47, 115\u2013119 (2017).","journal-title":"Anaerobe"},{"key":"748_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12905-019-0822-2","volume":"19","author":"MA Abd El Aziz","year":"2019","unstructured":"Abd El Aziz, M. A., Sharifipour, F., Abedi, P., Jahanfar, S. & Judge, H. M. Secnidazole for treatment of bacterial vaginosis: a systematic review. BMC Womens Health 19, 121 (2019).","journal-title":"BMC Womens Health"},{"key":"748_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejogrb.2019.05.013","volume":"238","author":"SM Elghazaly","year":"2019","unstructured":"Elghazaly, S. M. et al. Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 238, 125\u2013131 (2019).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"748_CR60","doi-asserted-by":"publisher","first-page":"517 e511","DOI":"10.1016\/j.ajog.2007.02.048","volume":"196","author":"JR Schwebke","year":"2007","unstructured":"Schwebke, J. R. & Desmond, R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am. J. Obstet. Gynecol. 196, 517 e511\u2013516 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR61","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fcimb.2019.00306","volume":"9","author":"K DeLong","year":"2019","unstructured":"DeLong, K. et al. Conceptual design of a universal donor screening approach for vaginal microbiota transplant. Front. Cell Infect. Microbiol. 9, 306 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/187569210792246326","volume":"8","author":"MR Rizkallah","year":"2010","unstructured":"Rizkallah, M. R., Saad, R. & Aziz, R. K. The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics. Curr. Pharmacogenom. Pers. Med. 8, 182\u2013193 (2010).","journal-title":"Curr. Pharmacogenom. Pers. Med."},{"key":"748_CR63","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/17425255.2018.1530216","volume":"14","author":"RK Aziz","year":"2018","unstructured":"Aziz, R. K., Hegazy, S. M., Yasser, R., Rizkallah, M. R. & ElRakaiby, M. T. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions. Expert Opin. Drug Metab. Toxicol. 14, 1043\u20131055 (2018).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"748_CR64","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander, J. L. et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat. Rev. Gastroenterol. Hepatol. 14, 356\u2013365 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"748_CR65","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/omi.2014.0018","volume":"18","author":"M ElRakaiby","year":"2014","unstructured":"ElRakaiby, M. et al. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18, 402\u2013414 (2014).","journal-title":"OMICS"},{"key":"748_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 7, 135 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"748_CR67","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2174\/187569212803901710","volume":"10","author":"RK Aziz","year":"2012","unstructured":"Aziz, R. K. Rethinking pharmacogenomics in an ecosystem: drug\u2013microbiome interactions, pharmacomicrobiomics, and personalized medicine for the human supraorganism. Curr. Pharmacogenom. Pers. Med. 10, 258\u2013261 (2012).","journal-title":"Curr. Pharmacogenom. Pers. Med."},{"key":"748_CR68","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2012.03.010","volume":"129","author":"LK Ursell","year":"2012","unstructured":"Ursell, L. K. et al. The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites. J. Allergy Clin. Immunol. 129, 1204\u20131208 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"748_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0483-7","volume":"6","author":"C Panebianco","year":"2018","unstructured":"Panebianco, C., Andriulli, A. & Pazienza, V. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. Microbiome 6, 92 (2018).","journal-title":"Microbiome"},{"key":"748_CR70","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1073\/pnas.0904489106","volume":"106","author":"TA Clayton","year":"2009","unstructured":"Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. & Nicholson, J. K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA 106, 14728\u201314733 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"748_CR71","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295\u2013298 (2013).","journal-title":"Science"},{"key":"748_CR72","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971\u2013976 (2013).","journal-title":"Science"},{"key":"748_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-S7-A10","volume":"12","author":"RK Aziz","year":"2011","unstructured":"Aziz, R. K. PharmacoMicrobiomics or how bugs modulate drugs: An educational initiative to explore the effects of human microbiome on drugs. BMC Bioinform. 12, A10 (2011).","journal-title":"BMC Bioinform."},{"key":"748_CR74","doi-asserted-by":"publisher","first-page":"e48053","DOI":"10.1371\/journal.pone.0048053","volume":"7","author":"RK Aziz","year":"2012","unstructured":"Aziz, R. K. et al. SEED servers: high-performance access to the SEED genomes, annotations, and metabolic models. PLoS ONE 7, e48053 (2012).","journal-title":"PLoS ONE"},{"key":"748_CR75","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkr988","volume":"40","author":"M Kanehisa","year":"2012","unstructured":"Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109\u2013D114 (2012).","journal-title":"Nucleic Acids Res."},{"key":"748_CR76","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/humu.20731","volume":"29","author":"RP Owen","year":"2008","unstructured":"Owen, R. P., Altman, R. B. & Klein, T. E. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum. Mutat. 29, 456\u2013460 (2008).","journal-title":"Hum. Mutat."},{"key":"748_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-1-48","volume":"1","author":"AP Davis","year":"2008","unstructured":"Davis, A. P., Murphy, C. G., Rosenstein, M. C., Wiegers, T. C. & Mattingly, C. J. The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study. BMC Med. Genom.1, 48 (2008).","journal-title":"BMC Med. Genom."},{"key":"748_CR78","doi-asserted-by":"publisher","first-page":"D786","DOI":"10.1093\/nar\/gkn580","volume":"37","author":"AP Davis","year":"2009","unstructured":"Davis, A. P. et al. Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks. Nucleic Acids Res. 37, D786\u2013D792 (2009).","journal-title":"Nucleic Acids Res."},{"key":"748_CR79","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/FPC.0b013e328337b8d6","volume":"20","author":"ER Gamazon","year":"2010","unstructured":"Gamazon, E. R. et al. PACdb: a database for cell-based pharmacogenomics. Pharmacogenet. Genom.20, 269\u2013273 (2010).","journal-title":"Pharmacogenet. Genom."},{"key":"748_CR80","doi-asserted-by":"publisher","first-page":"e1001377","DOI":"10.1371\/journal.pbio.1001377","volume":"10","author":"D Gevers","year":"2012","unstructured":"Gevers, D. et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol. 10, e1001377 (2012).","journal-title":"PLoS Biol."},{"key":"748_CR81","doi-asserted-by":"publisher","first-page":"D617","DOI":"10.1093\/nar\/gkt1078","volume":"42","author":"K Huang","year":"2014","unstructured":"Huang, K. et al. MetaRef: a pan-genomic database for comparative and community microbial genomics. Nucleic Acids Res. 42, D617\u2013D624 (2014).","journal-title":"Nucleic Acids Res."},{"key":"748_CR82","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1440-1746.2009.06120.x","volume":"25","author":"O Grundmann","year":"2010","unstructured":"Grundmann, O. & Yoon, S. L. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J. Gastroenterol. Hepatol. 25, 691\u2013699 (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"748_CR83","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.2174\/138161210794079227","volume":"16","author":"O Grundmann","year":"2010","unstructured":"Grundmann, O., Yoon, S. L. & Moshiree, B. Current developments for the diagnosis and treatment of irritable bowel syndrome. Curr. Pharm. Des. 16, 3638\u20133645 (2010).","journal-title":"Curr. Pharm. Des."},{"key":"748_CR84","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/gut.30.7.971","volume":"30","author":"VI Mathan","year":"1989","unstructured":"Mathan, V. I., Wiederman, J., Dobkin, J. F. & Lindenbaum, J. Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 30, 971\u2013977 (1989).","journal-title":"Gut"},{"key":"748_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000069784","volume":"49","author":"A Vermes","year":"2003","unstructured":"Vermes, A., Kuijper, E. J., Guchelaar, H. J. & Dankert, J. An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora. Chemotherapy 49, 17\u201323 (2003).","journal-title":"Chemotherapy"},{"key":"748_CR86","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.resmic.2010.04.003","volume":"161","author":"LS Steffens","year":"2010","unstructured":"Steffens, L. S. et al. Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole. Res. Microbiol. 161, 346\u2013354 (2010).","journal-title":"Res. Microbiol."},{"key":"748_CR87","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.resmic.2010.04.003","volume":"161","author":"LS Steffens","year":"2010","unstructured":"Steffens, L. S. et al. Corrigendum to: \u201cBacteroides fragilis RecA protein over expression causes resistance to metronidazole.\u201d Res. Microbiol. 161, 346\u2013354 (2010).","journal-title":"Res. Microbiol."},{"key":"748_CR88","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3109\/00498258709043976","volume":"17","author":"HA Strong","year":"1987","unstructured":"Strong, H. A., Renwick, A. G., George, C. F., Liu, Y. F. & Hill, M. J. The reduction of sulphinpyrazone and sulindac by intestinal bacteria. Xenobiotica 17, 685\u2013696 (1987).","journal-title":"Xenobiotica"},{"key":"748_CR89","doi-asserted-by":"publisher","unstructured":"Amabebe, E. & Anumba, D. O. C. Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.02184 (2020).","DOI":"10.3389\/fimmu.2020.02184"},{"key":"748_CR90","unstructured":"Amabebe, E. Analysis of Cervicovaginal Fluid Metabolome Microbiome in Relation to Preterm Birth. PhD thesis, Univ. Sheffield (2016)."},{"key":"748_CR91","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1749-6632.2011.06041.x","volume":"1230","author":"D Danielsson","year":"2011","unstructured":"Danielsson, D., Teigen, P. K. & Moi, H. The genital econiche: focus on microbiota and bacterial vaginosis. Ann. N. Y Acad. Sci. 1230, 48\u201358 (2011).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"748_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.humic.2021.100081","volume":"20","author":"O Goje","year":"2021","unstructured":"Goje, O., Shay, O. E., Markwei, M. & Padmanabhan, R. The effect of oral Metronidazole on the vaginal microbiome of patients with recurrent bacterial vaginosis: A pilot investigational study. Hum. Microbiome J. 20, 100081 (2021).","journal-title":"Hum. Microbiome J."},{"key":"748_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60671-6","volume":"10","author":"J van de Wijgert","year":"2020","unstructured":"van de Wijgert, J. et al. Intermittent Lactobacilli-containing vaginal probiotic or metronidazole use to prevent bacterial vaginosis recurrence: a pilot study incorporating microscopy and sequencing. Sci. Rep. 10, 3884 (2020).","journal-title":"Sci. Rep."},{"key":"748_CR94","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/infdis\/jiad261","volume":"228","author":"EL Plummer","year":"2023","unstructured":"Plummer, E. L. et al. Prevotella and gardnerella are associated with treatment failure following first-line antibiotics for bacterial vaginosis. J. Infect. Dis. 228, 646\u2013656 (2023).","journal-title":"J. Infect. Dis."},{"key":"748_CR95","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.aai9383","volume":"356","author":"NR Klatt","year":"2017","unstructured":"Klatt, N. R. et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science 356, 938\u2013945 (2017).","journal-title":"Science"},{"key":"748_CR96","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0140-6736(11)60878-7","volume":"378","author":"SS Karim","year":"2011","unstructured":"Karim, S. S., Kashuba, A. D., Werner, L. & Karim, Q. A. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. Lancet 378, 279\u2013281 (2011).","journal-title":"Lancet"},{"key":"748_CR97","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/infdis\/jix420","volume":"216","author":"R Donahue Carlson","year":"2017","unstructured":"Donahue Carlson, R. et al. The female genital tract microbiome is associated with vaginal antiretroviral drug concentrations in human immunodeficiency virus-infected women on antiretroviral therapy. J. Infect. Dis. 216, 990\u2013999 (2017).","journal-title":"J. Infect. Dis."},{"key":"748_CR98","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1097\/QAI.0b013e3182986ff8","volume":"63","author":"CG Thompson","year":"2013","unstructured":"Thompson, C. G., Cohen, M. S. & Kashuba, A. D. Antiretroviral pharmacology in mucosal tissues. J. Acquir Immune Defic. Syndr. 63, S240\u2013S247 (2013).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"748_CR99","doi-asserted-by":"publisher","unstructured":"Leyva-Gomez, G. et al. Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics11050217 (2019).","DOI":"10.3390\/pharmaceutics11050217"},{"key":"748_CR100","first-page":"283","volume":"12","author":"G Ventolini","year":"2016","unstructured":"Ventolini, G. Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis. Womens Health12, 283\u2013291 (2016).","journal-title":"Womens Health"},{"key":"748_CR101","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1021\/acs.molpharmaceut.5b00056","volume":"12","author":"AS Indulkar","year":"2015","unstructured":"Indulkar, A. S., Box, K. J., Taylor, R., Ruiz, R. & Taylor, L. S. pH-dependent liquid-liquid phase separation of highly supersaturated solutions of weakly basic drugs. Mol. Pharm. 12, 2365\u20132377 (2015).","journal-title":"Mol. Pharm."},{"key":"748_CR102","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1007\/s11095-014-1336-0","volume":"31","author":"O Kis","year":"2014","unstructured":"Kis, O., Walmsley, S. L. & Bendayan, R. In vitro and in situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agents. Pharm. Res. 31, 2404\u20132419 (2014).","journal-title":"Pharm. Res."},{"key":"748_CR103","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ijbiomac.2022.09.207","volume":"222","author":"E Szymanska","year":"2022","unstructured":"Szymanska, E. et al. Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate - The effect of vaginal pH on drug carrier performance. Int. J. Biol. Macromol. 222, 856\u2013867 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"748_CR104","doi-asserted-by":"publisher","unstructured":"Taneva, E. et al. Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.99545 (2018).","DOI":"10.1172\/jci.insight.99545"},{"key":"748_CR105","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1128\/AAC.02793-15","volume":"60","author":"E Taneva","year":"2015","unstructured":"Taneva, E. et al. Differential mechanisms of tenofovir and tenofovir disoproxil fumarate cellular transport and implications for topical preexposure prophylaxis. Antimicrob. Agents Chemother. 60, 1667\u20131675 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"748_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.799501","volume":"12","author":"AR Thurman","year":"2022","unstructured":"Thurman, A. R. et al. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using a 90-day tenofovir\/levonorgestrel vaginal ring. Front. Cell Infect. Microbiol. 12, 799501 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR107","doi-asserted-by":"publisher","unstructured":"Stafford, G. P. et al. Spontaneous preterm birth is associated with differential expression of vaginal metabolites by Lactobacilli-dominated microflora. Front. Physiol. https:\/\/doi.org\/10.3389\/fphys.2017.00615 (2017).","DOI":"10.3389\/fphys.2017.00615"},{"key":"748_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.792787","volume":"11","author":"N Zheng","year":"2021","unstructured":"Zheng, N., Guo, R., Wang, J., Zhou, W. & Ling, Z. Contribution of Lactobacillus iners to vaginal health and diseases: a systematic review. Front. Cell Infect. Microbiol. 11, 792787 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0223-9","volume":"5","author":"LM Kindinger","year":"2017","unstructured":"Kindinger, L. M. et al. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome 5, 6 (2017).","journal-title":"Microbiome"},{"key":"748_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/srep05136","volume":"4","author":"L Petricevic","year":"2014","unstructured":"Petricevic, L. et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci. Rep. 4, 5136 (2014).","journal-title":"Sci. Rep."},{"key":"748_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28620-1","volume":"13","author":"D Chan","year":"2022","unstructured":"Chan, D. et al. Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response. Nat. Commun. 13, 975 (2022).","journal-title":"Nat. Commun."},{"key":"748_CR112","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1067\/mob.2002.126987","volume":"187","author":"PS Ramsey","year":"2002","unstructured":"Ramsey, P. S., Ogburn, P. L. Jr., Harris, D. Y., Heise, R. H. & Ramin, K. D. Effect of vaginal pH on efficacy of the dinoprostone gel for cervical ripening\/labor induction. Am. J. Obstet. Gynecol. 187, 843\u2013846 (2002).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR113","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.18203\/2320-1770.ijrcog20160884","volume":"5","author":"M Kurian","year":"2016","unstructured":"Kurian, M., Rao, B. & Rao, A. A. S. Effect of vaginal pH on efficacy of dinoprostone gel for labour induction. Int. J. Reprod. Contracept. Obstet. Gynecol. 5, 1196\u20131201 (2016).","journal-title":"Int. J. Reprod. Contracept. Obstet. Gynecol."},{"key":"748_CR114","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5005\/jp-journals-10028-1316","volume":"53","author":"A Kumari","year":"2019","unstructured":"Kumari, A., Sharma, S. L., Pal, A. & Bhatia, V. Effect of vaginal pH on efficacy of the dinoprostone gel on labor induction and outcomes. J. Postgrad. Med. Educ. Res. 53, 72\u201374 (2019).","journal-title":"J. Postgrad. Med. Educ. Res."},{"key":"748_CR115","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14767050500123863","volume":"17","author":"S Chandra","year":"2005","unstructured":"Chandra, S., Allen, V., Lee, W., Fanning, C. & Young, D. The effect of vaginal pH on labor induction with vaginal misoprostol. J. Matern. Fetal Neonatal Med. 17, 387\u2013391 (2005).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"748_CR116","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1067\/mob.2000.107441","volume":"182","author":"PS Ramsey","year":"2000","unstructured":"Ramsey, P. S., Ogburn, P. L. Jr., Harris, D. Y., Heise, R. H. & Ramin, K. D. Effect of vaginal pH on efficacy of misoprostol for cervical ripening and labor induction. Am. J. Obstet. Gynecol. 182, 1616\u20131619 (2000).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR117","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","volume":"179","author":"ID Wilson","year":"2017","unstructured":"Wilson, I. D. & Nicholson, J. K. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl. Res. 179, 204\u2013222 (2017).","journal-title":"Transl. Res."},{"key":"748_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14943-3","volume":"8","author":"TM Nelson","year":"2018","unstructured":"Nelson, T. M. et al. Cigarette smoking is associated with an altered vaginal tract metabolomic profile. Sci. Rep. 8, 852 (2018).","journal-title":"Sci. Rep."},{"key":"748_CR119","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/clpt.2008.3","volume":"83","author":"NL Benowitz","year":"2008","unstructured":"Benowitz, N. L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther. 83, 531\u2013541 (2008).","journal-title":"Clin. Pharmacol. Ther."},{"key":"748_CR120","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/jcm.15.1.19-24.1982","volume":"15","author":"P Piot","year":"1982","unstructured":"Piot, P., Van Dyck, E., Totten, P. A. & Holmes, K. K. Identification of Gardnerella (Haemophilus) vaginalis. J. Clin. Microbiol. 15, 19\u201324 (1982).","journal-title":"J. Clin. Microbiol."},{"key":"748_CR121","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1128\/jcm.20.4.677-679.1984","volume":"20","author":"P Piot","year":"1984","unstructured":"Piot, P. et al. Biotypes of Gardnerella vaginalis. J. Clin. Microbiol. 20, 677\u2013679 (1984).","journal-title":"J. Clin. Microbiol."},{"key":"748_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.858155","volume":"12","author":"H Qin","year":"2022","unstructured":"Qin, H. & Xiao, B. Research progress on the correlation between gardnerella typing and bacterial vaginosis. Front. Cell Infect. Microbiol. 12, 858155 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR123","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/biolre\/ioab058","volume":"105","author":"OAG Tantengco","year":"2021","unstructured":"Tantengco, O. A. G., Vink, J., Medina, P. M. B. & Menon, R. Oxidative stress promotes cellular damages in the cervix: implications for normal and pathologic cervical function in human pregnancy\u2020. Biol. Reprod. 105, 204\u2013216 (2021).","journal-title":"Biol. Reprod."},{"key":"748_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-471","volume":"14","author":"RM Brotman","year":"2014","unstructured":"Brotman, R. M. et al. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect. Dis. 14, 471 (2014).","journal-title":"BMC Infect. Dis."},{"key":"748_CR125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.48095\/cccg202122","volume":"86","author":"J Tuzil","year":"2021","unstructured":"Tuzil, J., Filkova, B., Malina, J., Kerestes, J. & Dolezal, T. Smoking in women with chronic vaginal discomfort is not associated with decreased abundance of Lactobacillus spp. but promotes Mobiluncus and Gardnerella spp. overgrowth - secondary analysis of trial data including microbio-me analysis. Ceska Gynekol. 86, 22\u201329 (2021).","journal-title":"Ceska Gynekol."},{"key":"748_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919728","volume":"13","author":"MS Kwon","year":"2022","unstructured":"Kwon, M. S. & Lee, H. K. Host and Microbiome Interplay Shapes the Vaginal Microenvironment. Front. Immunol. 13, 919728 (2022).","journal-title":"Front. Immunol."},{"key":"748_CR127","doi-asserted-by":"publisher","first-page":"e36466","DOI":"10.1371\/journal.pone.0036466","volume":"7","author":"K Aagaard","year":"2012","unstructured":"Aagaard, K. et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE 7, e36466 (2012).","journal-title":"PLoS ONE"},{"key":"748_CR128","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"THMP Consortium","year":"2012","unstructured":"Consortium, T. H. M. P. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","journal-title":"Nature"},{"key":"748_CR129","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ismej.2007.3","volume":"1","author":"C Jernberg","year":"2007","unstructured":"Jernberg, C., Lofmark, S., Edlund, C. & Jansson, J. K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1, 56\u201366 (2007).","journal-title":"ISME J."},{"key":"748_CR130","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.meegid.2018.06.020","volume":"64","author":"R Ghotaslou","year":"2018","unstructured":"Ghotaslou, R. et al. Mechanisms of Bacteroides fragilis resistance to metronidazole. Infect. Genet. Evol. 64, 156\u2013163 (2018).","journal-title":"Infect. Genet. Evol."},{"key":"748_CR131","doi-asserted-by":"publisher","first-page":"e53997","DOI":"10.1371\/journal.pone.0053997","volume":"8","author":"A Swidsinski","year":"2013","unstructured":"Swidsinski, A. et al. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS ONE8, e53997 (2013).","journal-title":"PLoS ONE"},{"key":"748_CR132","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.micinf.2011.12.009","volume":"14","author":"CN Marrs","year":"2012","unstructured":"Marrs, C. N. et al. Evidence for Gardnerella vaginalis uptake and internalization by squamous vaginal epithelial cells: implications for the pathogenesis of bacterial vaginosis. Microbes Infect. 14, 500\u2013508 (2012).","journal-title":"Microbes Infect."},{"key":"748_CR133","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1128\/IAI.66.10.5041-5047.1998","volume":"66","author":"GP Jarosik","year":"1998","unstructured":"Jarosik, G. P., Land, C. B., Duhon, P., Chandler, R. Jr. & Mercer, T. Acquisition of iron by Gardnerella vaginalis. Infect. Immun. 66, 5041\u20135047 (1998).","journal-title":"Infect. Immun."},{"key":"748_CR134","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1128\/IAI.68.6.3443-3447.2000","volume":"68","author":"GP Jarosik","year":"2000","unstructured":"Jarosik, G. P. & Land, C. B. Identification of a human lactoferrin-binding protein in Gardnerella vaginalis. Infect. Immun. 68, 3443\u20133447 (2000).","journal-title":"Infect. Immun."},{"key":"748_CR135","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fcimb.2019.00374","volume":"9","author":"S Khan","year":"2019","unstructured":"Khan, S., Voordouw, M. J. & Hill, J. E. Competition Among Gardnerella Subgroups From the Human Vaginal Microbiome. Front. Cell Infect. Microbiol. 9, 374 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR136","doi-asserted-by":"publisher","first-page":"e9836","DOI":"10.1371\/journal.pone.0009836","volume":"5","author":"HE Jakobsson","year":"2010","unstructured":"Jakobsson, H. E. et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE5, e9836 (2010).","journal-title":"PLoS ONE"},{"key":"748_CR137","doi-asserted-by":"publisher","first-page":"e0172522","DOI":"10.1371\/journal.pone.0172522","volume":"12","author":"L Hardy","year":"2017","unstructured":"Hardy, L. et al. The presence of the putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis biofilm. PLoS ONE12, e0172522 (2017).","journal-title":"PLoS ONE"},{"key":"748_CR138","first-page":"450 e451","volume":"204","author":"GL Santiago","year":"2011","unstructured":"Santiago, G. L. et al. Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase. Am. J. Obstet. Gynecol. 204, 450 e451\u2013450.e457 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"748_CR139","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1128\/jcm.30.3.663-666.1992","volume":"30","author":"AM Briselden","year":"1992","unstructured":"Briselden, A. M., Moncla, B. J., Stevens, C. E. & Hillier, S. L. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J. Clin. Microbiol. 30, 663\u2013666 (1992).","journal-title":"J. Clin. Microbiol."},{"key":"748_CR140","doi-asserted-by":"publisher","first-page":"813520","DOI":"10.3389\/fcimb.2021.813520","volume":"11","author":"CST Ferreira","year":"2021","unstructured":"Ferreira, C. S. T., Marconi, C., Parada, C., Ravel, J. & da Silva, M. G. Sialidase activity in the cervicovaginal fluid is associated with changes in bacterial components of Lactobacillus-deprived microbiota. Front. Cell Infect. Microbiol. 11, 813520 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR141","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/infdis\/jiy704","volume":"220","author":"NM Gilbert","year":"2019","unstructured":"Gilbert, N. M. et al. Gardnerella vaginalis and Prevotella bivia trigger distinct and overlapping phenotypes in a mouse model of bacterial vaginosis. J. Infect. Dis. 220, 1099\u20131108 (2019).","journal-title":"J. Infect. Dis."},{"key":"748_CR142","doi-asserted-by":"publisher","first-page":"12067","DOI":"10.1074\/jbc.M113.453654","volume":"288","author":"WG Lewis","year":"2013","unstructured":"Lewis, W. G., Robinson, L. S., Gilbert, N. M., Perry, J. C. & Lewis, A. L. Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J. Biol. Chem. 288, 12067\u201312079 (2013).","journal-title":"J. Biol. Chem."},{"key":"748_CR143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1574-695X.2012.00940.x","volume":"65","author":"M Pleckaityte","year":"2012","unstructured":"Pleckaityte, M., Janulaitiene, M., Lasickiene, R. & Zvirbliene, A. Genetic and biochemical diversity of Gardnerella vaginalis strains isolated from women with bacterial vaginosis. FEMS Immunol. Med. Microbiol. 65, 69\u201377 (2012).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"748_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41469-8","volume":"13","author":"J Novak","year":"2023","unstructured":"Novak, J. et al. Cervicovaginal Gardnerella sialidase-encoding gene in persistent human papillomavirus infection. Sci. Rep. 13, 14266 (2023).","journal-title":"Sci. Rep."},{"key":"748_CR145","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","volume":"8","author":"D Sharma","year":"2019","unstructured":"Sharma, D., Misba, L. & Khan, A. U. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob. Resist. Infect. Control 8, 76 (2019).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"748_CR146","doi-asserted-by":"publisher","first-page":"e0272012","DOI":"10.1371\/journal.pone.0272012","volume":"17","author":"A Mollin","year":"2022","unstructured":"Mollin, A., Katta, M., Sobel, J. D. & Akins, R. A. Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes. PLoS ONE17, e0272012 (2022).","journal-title":"PLoS ONE"},{"key":"748_CR147","doi-asserted-by":"publisher","first-page":"e0256445","DOI":"10.1371\/journal.pone.0256445","volume":"16","author":"E Turner","year":"2021","unstructured":"Turner, E., Sobel, J. D. & Akins, R. A. Prognosis of recurrent bacterial vaginosis based on longitudinal changes in abundance of Lactobacillus and specific species of Gardnerella. PLoS ONE16, e0256445 (2021).","journal-title":"PLoS ONE"},{"key":"748_CR148","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad007","volume":"10","author":"E Armstrong","year":"2023","unstructured":"Armstrong, E. et al. Treatment success following standard antibiotic treatment for bacterial vaginosis is not associated with pretreatment genital immune or microbial parameters. Open Forum Infect. Dis. 10, ofad007 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"748_CR149","doi-asserted-by":"publisher","first-page":"e0154086","DOI":"10.1371\/journal.pone.0154086","volume":"11","author":"C Gottschick","year":"2016","unstructured":"Gottschick, C. et al. Screening of compounds against Gardnerella vaginalis biofilms. PLoS ONE11, e0154086 (2016).","journal-title":"PLoS ONE"},{"key":"748_CR150","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1361825","volume":"2020","author":"T Li","year":"2020","unstructured":"Li, T. et al. Antimicrobial susceptibility testing of metronidazole and clindamycin against Gardnerella vaginalis in planktonic and biofilm formation. Can. J. Infect. Dis. Med. Microbiol. 2020, 1361825 (2020).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"748_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2022.100101","volume":"5","author":"W Johnston","year":"2023","unstructured":"Johnston, W. et al. In vitro bacterial vaginosis biofilm community manipulation using endolysin therapy. Biofilm 5, 100101 (2023).","journal-title":"Biofilm"},{"key":"748_CR152","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/jac\/dkac155","volume":"77","author":"AS Rosca","year":"2022","unstructured":"Rosca, A. S. et al. In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence. J. Antimicrob. Chemother. 77, 2183\u20132190 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"748_CR153","doi-asserted-by":"publisher","unstructured":"Castro, J., Rosca, A. S., Muzny, C. A. & Cerca, N. Atopobium vaginae and Prevotella bivia Are Able to Incorporate and Influence Gene Expression in a Pre-Formed Gardnerella vaginalis Biofilm. Pathogens https:\/\/doi.org\/10.3390\/pathogens10020247 (2021).","DOI":"10.3390\/pathogens10020247"},{"key":"748_CR154","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41396-018-0337-0","volume":"13","author":"J Castro","year":"2019","unstructured":"Castro, J., Machado, D. & Cerca, N. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. ISME J. 13, 1306\u20131317 (2019).","journal-title":"ISME J."},{"key":"748_CR155","doi-asserted-by":"publisher","first-page":"e0136658","DOI":"10.1371\/journal.pone.0136658","volume":"10","author":"L Hardy","year":"2015","unstructured":"Hardy, L. et al. Unravelling the bacterial vaginosis-associated biofilm: a multiplex Gardnerella vaginalis and Atopobium vaginae fluorescence in situ hybridization assay using peptide nucleic acid probes. PLoS ONE10, e0136658 (2015).","journal-title":"PLoS ONE"},{"key":"748_CR156","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1089\/aid.2013.0032","volume":"29","author":"T Zhou","year":"2013","unstructured":"Zhou, T., Hu, M., Cost, M., Poloyac, S. & Rohan, L. Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research. AIDS Res. Hum. Retroviruses 29, 1496\u20131503 (2013).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"748_CR157","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1089\/aid.2013.0281","volume":"30","author":"T Zhou","year":"2014","unstructured":"Zhou, T., Hu, M., Pearlman, A., Patton, D. & Rohan, L. Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque. AIDS Res. Hum. Retroviruses 30, 1106\u20131116 (2014).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"748_CR158","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.anaerobe.2017.04.014","volume":"45","author":"AA Medina-Colorado","year":"2017","unstructured":"Medina-Colorado, A. A. et al. Vaginal ecosystem modeling of growth patterns of anaerobic bacteria in microaerophilic conditions. Anaerobe 45, 10\u201318 (2017).","journal-title":"Anaerobe"},{"key":"748_CR159","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3389\/fmicb.2018.00975","volume":"9","author":"E Marin","year":"2018","unstructured":"Marin, E. et al. Unraveling Gardnerella vaginalis surface proteins using cell shaving proteomics. Front. Microbiol. 9, 975 (2018).","journal-title":"Front. Microbiol."},{"key":"748_CR160","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1128\/IAI.72.12.6757-6763.2004","volume":"72","author":"HS Garmory","year":"2004","unstructured":"Garmory, H. S. & Titball, R. W. ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect. Immun. 72, 6757\u20136763 (2004).","journal-title":"Infect. Immun."},{"key":"748_CR161","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.ajpath.2024.08.009","volume":"194","author":"YL Zhang","year":"2024","unstructured":"Zhang, Y. L. et al. Lipopolysaccharide triggers luminal acidification to promote defense against bacterial infection in vaginal epithelium. Am. J. Pathol. 194, 2290\u20132301 (2024).","journal-title":"Am. J. Pathol."},{"key":"748_CR162","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bcp.2016.07.009","volume":"116","author":"T Zhou","year":"2016","unstructured":"Zhou, T., Hu, M., Pearlman, A. & Rohan, L. C. Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing. Biochem. Pharma116, 162\u2013175 (2016).","journal-title":"Biochem. Pharma"},{"key":"748_CR163","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejpb.2015.03.031","volume":"93","author":"M Berlin","year":"2015","unstructured":"Berlin, M. et al. Advances and challenges in PBPK modeling\u2013analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base. Eur. J. Pharm. Biopharm. 93, 267\u2013280 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"748_CR164","doi-asserted-by":"publisher","first-page":"20882","DOI":"10.1021\/acsomega.0c02329","volume":"5","author":"P Webster","year":"2020","unstructured":"Webster, P., Saito, K., Cortez, J., Ramirez, C. & Baum, M. M. Concentrative nucleoside transporter 3 is located on microvilli of vaginal epithelial cells. ACS Omega 5, 20882\u201320889 (2020).","journal-title":"ACS Omega"},{"key":"748_CR165","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/MMBR.00001-07","volume":"71","author":"J Lubelski","year":"2007","unstructured":"Lubelski, J., Konings, W. N. & Driessen, A. J. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev. 71, 463\u2013476 (2007).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"748_CR166","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.biochem.73.011303.073626","volume":"73","author":"AL Davidson","year":"2004","unstructured":"Davidson, A. L. & Chen, J. ATP-binding cassette transporters in bacteria. Annu. Rev. Biochem 73, 241\u2013268 (2004).","journal-title":"Annu. Rev. Biochem"},{"key":"748_CR167","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrm2646","volume":"10","author":"DC Rees","year":"2009","unstructured":"Rees, D. C., Johnson, E. & Lewinson, O. ABC transporters: the power to change. Nat. Rev. Mol. Cell Biol. 10, 218\u2013227 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"748_CR168","doi-asserted-by":"publisher","first-page":"14","DOI":"10.12703\/P7-14","volume":"7","author":"S Wilkens","year":"2015","unstructured":"Wilkens, S. Structure and mechanism of ABC transporters. F1000Prime Rep. 7, 14 (2015).","journal-title":"F1000Prime Rep."},{"key":"748_CR169","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00424-020-02379-0","volume":"472","author":"JM Jeckelmann","year":"2020","unstructured":"Jeckelmann, J. M. & Erni, B. Transporters of glucose and other carbohydrates in bacteria. Pflug. Arch. 472, 1129\u20131153 (2020).","journal-title":"Pflug. Arch."},{"key":"748_CR170","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2958.2010.07199.x","volume":"77","author":"DW Abbott","year":"2010","unstructured":"Abbott, D. W. et al. The molecular basis of glycogen breakdown and transport in Streptococcus pneumoniae. Mol. Microbiol. 77, 183\u2013199 (2010).","journal-title":"Mol. Microbiol."},{"key":"748_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02635-9","volume":"23","author":"MT France","year":"2022","unstructured":"France, M. T. et al. Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data. Genome Biol. 23, 66 (2022).","journal-title":"Genome Biol."},{"key":"748_CR172","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/viru.23724","volume":"4","author":"SM Soto","year":"2013","unstructured":"Soto, S. M. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 4, 223\u2013229 (2013).","journal-title":"Virulence"},{"key":"748_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-017-0012-7","volume":"3","author":"J Castro","year":"2017","unstructured":"Castro, J. et al. Comparative transcriptomic analysis of Gardnerella vaginalis biofilms vs. planktonic cultures using RNA-seq. NPJ Biofilms Microbiomes 3, 3 (2017).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"748_CR174","doi-asserted-by":"publisher","unstructured":"Zhang, K. et al. Transcriptomic and proteomic analysis of Gardnerella vaginalis responding to acidic pH and hydrogen peroxide stress. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms11030695 (2023).","DOI":"10.3390\/microorganisms11030695"},{"key":"748_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1009798","volume":"13","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Antibiotic resistance and pathogenicity assessment of various Gardnerella sp. strains in local China. Front. Microbiol. 13, 1009798 (2022).","journal-title":"Front. Microbiol."},{"key":"748_CR176","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbamem.2007.02.007","volume":"1768","author":"GL Lorca","year":"2007","unstructured":"Lorca, G. L. et al. Transport capabilities of eleven gram-positive bacteria: comparative genomic analyses. Biochim. Biophys. Acta 1768, 1342\u20131366 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"748_CR177","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1099\/13500872-145-8-2077","volume":"145","author":"JP Bannantine","year":"1999","unstructured":"Bannantine, J. P. & Rockey, D. D. Use of primate model system to identify Chlamydia trachomatis protein antigens recognized uniquely in the context of infection. Microbiology 145, 2077\u20132085 (1999).","journal-title":"Microbiology"},{"key":"748_CR178","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0378-1097(03)00310-0","volume":"222","author":"MJ Hughes","year":"2003","unstructured":"Hughes, M. J. et al. Novel protein vaccine candidates against group B streptococcal infection identified using alkaline phosphatase fusions. FEMS Microbiol. Lett. 222, 263\u2013271 (2003).","journal-title":"FEMS Microbiol. Lett."},{"key":"748_CR179","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/carcin\/16.6.1391","volume":"16","author":"FM Farin","year":"1995","unstructured":"Farin, F. M., Bigler, L. G., Oda, D., McDougall, J. K. & Omiecinski, C. J. Expression of cytochrome P450 and microsomal exposide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6\/E7 genes. Carcinogenesis 16, 1670 (1995).","journal-title":"Carcinogenesis"},{"key":"748_CR180","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s004280050359","volume":"434","author":"T Yokose","year":"1999","unstructured":"Yokose, T. et al. Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch. 434, 401\u2013411 (1999).","journal-title":"Virchows Arch."},{"key":"748_CR181","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1525-1438.1993.03030159.x","volume":"3","author":"KR Patel","year":"1993","unstructured":"Patel, K. R. et al. Expression of cytochrome P450 enzymes in the cervix. An immunohistochemical study. Int. J. Gynecol. Cancer 3, 159\u2013163 (1993).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"748_CR182","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","volume":"149","author":"A Sharma","year":"2019","unstructured":"Sharma, A., Gupta, V. K. & Pathania, R. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J. Med. Res. 149, 129\u2013145 (2019).","journal-title":"Indian J. Med. Res."},{"key":"748_CR183","doi-asserted-by":"publisher","unstructured":"Zwama, M. & Nishino, K. Ever-adapting RND efflux pumps in Gram-negative multidrug-resistant pathogens: a race against time. Antibiotics https:\/\/doi.org\/10.3390\/antibiotics10070774 (2021).","DOI":"10.3390\/antibiotics10070774"},{"key":"748_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.737288","volume":"12","author":"K Nishino","year":"2021","unstructured":"Nishino, K., Yamasaki, S., Nakashima, R., Zwama, M. & Hayashi-Nishino, M. Function and inhibitory mechanisms of multidrug efflux pumps. Front. Microbiol. 12, 737288 (2021).","journal-title":"Front. Microbiol."},{"key":"748_CR185","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/dkg050","volume":"51","author":"MA Webber","year":"2003","unstructured":"Webber, M. A. & Piddock, L. J. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51, 9\u201311 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"748_CR186","doi-asserted-by":"publisher","first-page":"a007385","DOI":"10.1101\/cshperspect.a007385","volume":"2","author":"RJ Shattock","year":"2012","unstructured":"Shattock, R. J. & Rosenberg, Z. Microbicides: topical prevention against HIV. Cold Spring Harb. Perspect. Med. 2, a007385 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"748_CR187","doi-asserted-by":"publisher","unstructured":"Pandey, M. et al. Promising drug delivery approaches to treat microbial infections in the vagina: a recent update. Polymers https:\/\/doi.org\/10.3390\/polym13010026 (2020).","DOI":"10.3390\/polym13010026"},{"key":"748_CR188","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1517\/17425247.2014.924499","volume":"11","author":"TW Wong","year":"2014","unstructured":"Wong, T. W., Dhanawat, M. & Rathbone, M. J. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development. Expert Opin. Drug Deliv. 11, 1419\u20131434 (2014).","journal-title":"Expert Opin. Drug Deliv."},{"key":"748_CR189","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3109\/10717544.2014.928760","volume":"23","author":"HS Johal","year":"2016","unstructured":"Johal, H. S., Garg, T., Rath, G. & Goyal, A. K. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 23, 550\u2013563 (2016).","journal-title":"Drug Deliv."},{"key":"748_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104012","volume":"29","author":"MTM Subi","year":"2024","unstructured":"Subi, M. T. M., Selvasudha, N. & Vasanthi, H. R. Vaginal drug delivery system: a promising route of drug administration for local and systemic diseases. Drug Discov. Today 29, 104012 (2024).","journal-title":"Drug Discov. Today"},{"key":"748_CR191","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fendo.2018.00568","volume":"9","author":"E Amabebe","year":"2018","unstructured":"Amabebe, E. & Anumba, D. O. C. Psychosocial stress, cortisol levels, and maintenance of vaginal health. Front. Endocrinol.9, 568 (2018).","journal-title":"Front. Endocrinol."},{"key":"748_CR192","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/423963","volume":"39","author":"CL Haggerty","year":"2004","unstructured":"Haggerty, C. L. et al. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin. Infect. Dis. 39, 990\u2013995 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"748_CR193","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fmicb.2016.00747","volume":"7","author":"B Shaskolskiy","year":"2016","unstructured":"Shaskolskiy, B. et al. Drug resistance mechanisms in bacteria causing sexually transmitted diseases and associated with vaginosis. Front. Microbiol. 7, 747 (2016).","journal-title":"Front. Microbiol."},{"key":"748_CR194","doi-asserted-by":"publisher","unstructured":"Schuyler, J. A., Mordechai, E., Adelson, M. E., Gygax, S. E. & Hilbert, D. W. Draft genome sequence of a metronidazole-resistant derivative of Gardnerella vaginalis strain ATCC 14019. Genome Announc https:\/\/doi.org\/10.1128\/genomeA.01345-15 (2015).","DOI":"10.1128\/genomeA.01345-15"},{"key":"748_CR195","doi-asserted-by":"publisher","unstructured":"Schuyler, J. A. et al. Draft genome sequence of a metronidazole-resistant Gardnerella vaginalis isolate. Genome Announc https:\/\/doi.org\/10.1128\/genomeA.00992-15 (2015).","DOI":"10.1128\/genomeA.00992-15"},{"key":"748_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2015.10.006","volume":"84","author":"JA Schuyler","year":"2016","unstructured":"Schuyler, J. A. et al. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn. Microbiol. Infect. Dis. 84, 1\u20133 (2016).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"748_CR197","first-page":"155","volume":"26","author":"P Nagaraja","year":"2008","unstructured":"Nagaraja, P. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis. Indian J. Med. Microbiol. 26, 155\u2013157 (2008).","journal-title":"Indian J. Med. Microbiol."},{"key":"748_CR198","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1086\/647939","volume":"50","author":"S Lofmark","year":"2010","unstructured":"Lofmark, S., Edlund, C. & Nord, C. E. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin. Infect. Dis. 50, S16\u2013S23 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"748_CR199","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jac\/dkx351","volume":"73","author":"SA Dingsdag","year":"2018","unstructured":"Dingsdag, S. A. & Hunter, N. Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms. J. Antimicrob. Chemother. 73, 265\u2013279 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"748_CR200","doi-asserted-by":"publisher","first-page":"e00204","DOI":"10.1128\/mBio.00204-15","volume":"6","author":"S Srinivasan","year":"2015","unstructured":"Srinivasan, S. et al. Metabolic signatures of bacterial vaginosis. mBio 6, e00204\u2013e00215 (2015).","journal-title":"mBio"},{"key":"748_CR201","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.anaerobe.2013.03.001","volume":"21","author":"Z Eitel","year":"2013","unstructured":"Eitel, Z., Soki, J., Urban, E., Nagy, E. & Infection, E. S. G.oA. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe 21, 43\u201349 (2013).","journal-title":"Anaerobe"},{"key":"748_CR202","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.1128\/AEM.00973-07","volume":"73","author":"TT Van","year":"2007","unstructured":"Van, T. T., Moutafis, G., Tran, L. T. & Coloe, P. J. Antibiotic resistance in food-borne bacterial contaminants in Vietnam. Appl. Environ. Microbiol. 73, 7906\u20137911 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"748_CR203","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.micpath.2018.11.046","volume":"127","author":"A Javed","year":"2019","unstructured":"Javed, A., Parvaiz, F. & Manzoor, S. Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it\u2019s associated resistance patterns. Microb. Pathog. 127, 21\u201330 (2019).","journal-title":"Microb. Pathog."},{"key":"748_CR204","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/OLQ.0000000000000123","volume":"41","author":"T Aguin","year":"2014","unstructured":"Aguin, T., Akins, R. A. & Sobel, J. D. High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study. Sex. Transm. Dis. 41, 290\u2013291 (2014).","journal-title":"Sex. Transm. Dis."},{"key":"748_CR205","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey, K. R., Naik, S. R. & Vakil, B. V. Probiotics, prebiotics and synbiotics- a review. J. Food Sci. Technol. 52, 7577\u20137587 (2015).","journal-title":"J. Food Sci. Technol."},{"key":"748_CR206","doi-asserted-by":"publisher","unstructured":"Al-Habsi, N. et al. Health benefits of prebiotics, probiotics, synbiotics, and postbiotics. Nutrients https:\/\/doi.org\/10.3390\/nu16223955 (2024).","DOI":"10.3390\/nu16223955"},{"key":"748_CR207","doi-asserted-by":"publisher","unstructured":"Martyniak, A., Medynska-Przeczek, A., Wedrychowicz, A., Skoczen, S. & Tomasik, P. J. Prebiotics, probiotics, synbiotics, paraprobiotics and postbiotic compounds in IBD. Biomolecules https:\/\/doi.org\/10.3390\/biom11121903 (2021).","DOI":"10.3390\/biom11121903"},{"key":"748_CR208","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tjog.2024.03.004","volume":"63","author":"M Abavisani","year":"2024","unstructured":"Abavisani, M., Sahebi, S., Dadgar, F., Peikfalak, F. & Keikha, M. The role of probiotics as adjunct treatment in the prevention and management of gynecological infections: An updated meta-analysis of 35 RCT studies. Taiwan J. Obstet. Gynecol. 63, 357\u2013368 (2024).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"748_CR209","doi-asserted-by":"publisher","unstructured":"Ali, M. S. et al. Probiotics and Postbiotics as an Alternative to Antibiotics: An Emphasis on Pigs. Pathogens 12, https:\/\/doi.org\/10.3390\/pathogens12070874 (2023).","DOI":"10.3390\/pathogens12070874"},{"key":"748_CR210","doi-asserted-by":"publisher","first-page":"1114364","DOI":"10.3389\/fcimb.2023.1114364","volume":"13","author":"X Shen","year":"2023","unstructured":"Shen, X. et al. Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota. Front. Cell Infect. Microbiol. 13, 1114364 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"748_CR211","doi-asserted-by":"publisher","unstructured":"Landlinger, C. et al. Engineered phage endolysin eliminates gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo. Pathogens https:\/\/doi.org\/10.3390\/pathogens10010054 (2021).","DOI":"10.3390\/pathogens10010054"},{"key":"748_CR212","doi-asserted-by":"publisher","first-page":"297","DOI":"10.20517\/evcna.2024.21","volume":"5","author":"E Amabebe","year":"2024","unstructured":"Amabebe, E. et al. Cargo exchange between human and bacterial extracellular vesicles in gestational tissues: a new paradigm in communication and immune development. Extracell. Vesicles Circ. Nucleic Acids 5, 297\u2013328 (2024).","journal-title":"Extracell. Vesicles Circ. Nucleic Acids"},{"key":"748_CR213","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200872R","volume":"36","author":"OAG Tantengco","year":"2022","unstructured":"Tantengco, O. A. G. et al. Modeling ascending Ureaplasma parvum infection through the female reproductive tract using vagina-cervix-decidua-organ-on-a-chip and feto-maternal interface-organ-on-a-chip. FASEB J. 36, e22551 (2022).","journal-title":"FASEB J."},{"key":"748_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.931609","volume":"10","author":"OAG Tantengco","year":"2022","unstructured":"Tantengco, O. A. G. et al. Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery. Front. Cell Dev. Biol. 10, 931609 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"748_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01400-1","volume":"10","author":"G Mahajan","year":"2022","unstructured":"Mahajan, G. et al. Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip. Microbiome 10, 201 (2022).","journal-title":"Microbiome"},{"key":"748_CR216","doi-asserted-by":"publisher","unstructured":"Swidsinski, A. et al. Antimicrobial susceptibility of microbiota in bacterial vaginosis using fluorescence in situ hybridization. Pathogens https:\/\/doi.org\/10.3390\/pathogens11040456 (2022).","DOI":"10.3390\/pathogens11040456"},{"key":"748_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00671-4","volume":"11","author":"M Cavanagh","year":"2025","unstructured":"Cavanagh, M. et al. Vaginal host immune-microbiome-metabolite interactions associated with spontaneous preterm birth in a predominantly white cohort. NPJ Biofilms Microbiomes 11, 52 (2025).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"748_CR218","doi-asserted-by":"publisher","unstructured":"Witkin, S. S. et al. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. mBio https:\/\/doi.org\/10.1128\/mBio.00460-13 (2013).","DOI":"10.1128\/mBio.00460-13"},{"key":"748_CR219","doi-asserted-by":"publisher","unstructured":"Huang, L. et al. Bacterial multidrug efflux pumps at the frontline of antimicrobial resistance: an overview. Antibiotics https:\/\/doi.org\/10.3390\/antibiotics11040520 (2022).","DOI":"10.3390\/antibiotics11040520"},{"key":"748_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46938-w","volume":"15","author":"P Laborda","year":"2024","unstructured":"Laborda, P. et al. Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. Nat. Commun. 15, 2584 (2024).","journal-title":"Nat. Commun."},{"key":"748_CR221","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/jac\/dky042","volume":"73","author":"I Alav","year":"2018","unstructured":"Alav, I., Sutton, J. M. & Rahman, K. M. Role of bacterial efflux pumps in biofilm formation. J. Antimicrob. Chemother. 73, 2003\u20132020 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"748_CR222","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3389\/fmicb.2020.01935","volume":"11","author":"G Fanelli","year":"2020","unstructured":"Fanelli, G., Pasqua, M., Colonna, B., Prosseda, G. & Grossi, M. Expression profile of multidrug resistance efflux pumps during intracellular life of adherent-invasive Escherichia coli strain LF82. Front. Microbiol. 11, 1935 (2020).","journal-title":"Front. Microbiol."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00748-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00748-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00748-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:04:28Z","timestamp":1751360668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00748-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":222,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00748-0","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}